London Calling 2025 - Speakers
Speakers
Check out the line up of speakers at London Calling 2025.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
Oxford Nanopore Technologies
Eloisa Arbustini
)
- Job title
- Institution
- IRCCS Foundation Policlinico San Matteo, Italy
- Biography
Dr Eloisa Arbustini, certified in Cardiology, Pathological Anatomy, and Genetics, leads the Center for Inherited Diseases at the IRCCS Foundation Policlinico San Matteo in Pavia, Italy, a Medical Center of Excellence (Deliberation No. 0080/CdA 26.04.2007). She serves on the boards of scientific societies and journals and is a member of the Scientific Committee of the Istituto Superiore di Sanità under the Italian Ministry of Health. Her expertise spans clinical, diagnostic, and research advancements in hereditary diseases.
- Recent publications
Elliott, P. et al. Integration of genetic testing into diagnostic pathways for cardiomyopathies: a clinical consensus statement by the ESC Council on Cardiovascular Genomics. Eur Heart J. 46(4):344–353 (2025).
DOI: 10.1093/eurheartj/ehae747Arbustini, E. et al. Interpretation and actionability of genetic variants in cardiomyopathies: a position statement from the European Society of Cardiology Council on cardiovascular genomics. Eur Heart J. 43(20):1901–1916 (2022).
DOI: 10.1093/eurheartj/ehab895. PMID: 35089333Arbustini, E., Urtis, M., and Elliott, P. Interpretation of genetic variants depends on a clinically guided integration of phenotype and molecular data. Eur Heart J. 43(27):2638–2639 (2022).
DOI: 10.1093/eurheartj/ehac264Urtis, M. et al. Unambiguous Interpretation of the Pathogenicity of the GLA c.547+3A>G Variant Causing Fabry Disease. Genes (Basel) 15(9):1212 (2024).
DOI: 10.3390/genes15091212
Talks at this conference
Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.